Assignee
PROVIDENCE HEALTH & SERVICES - OREGON
US·7 granted patents·9 pending applications·2 citations·filing 2014–2024
Top patents by PatentIndex Score
16 records- 0176US11572541B2Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancerPROVIDENCE HEALTH & SERVICES—OREGON·Filed 2018·Granted Feb 7, 2023·2 cites·10 claims
- 0269US12358968B2Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancerPROVIDENCE HEALTH & SERVICES—OREGON·Filed 2022·Granted Jul 15, 2025·0 cites·18 claims
- 0365US2014186292A1Defective ribosomal products in blebs (dribbles) and methods of use to stimulate an immune responsePROVIDENCE HEALTH & SERVICES OREGON·Filed 2014·Application pending·0 cites
- 0459US2024345096A1Method of identifying spliced peptidePROVIDENCE HEALTH & SERVICES OREGON·Filed 2022·Application pending·0 cites
- 0559US2025073268A1Chimeric cd40 polypeptides and methods of use in immunotherapyPROVIDENCE HEALTH & SERVICES OREGON·Filed 2023·Application pending·0 cites
- 0655US2024002795A1T cell receptors specific for a mutant form of the ret oncogene and uses thereofPROVIDENCE HEALTH & SERVICES OREGON·Filed 2021·Application pending·0 cites
- 0751US2017202949A1Defective ribosomal products in blebs (dribbles) and methods of use to stimulate an immune responsePROVIDENCE HEALTH & SERVICES - OREGON·Filed 2016·Application pending·0 cites
- 0848US12486314B2Fusion polypeptides binding antibody Fc domains and integrin and methods of usePROVIDENCE HEALTH & SERVICES—OREGON·Filed 2020·Granted Dec 2, 2025·0 cites·14 claims
- 0948US12336973B2Cancer therapeutic compositions and methods targeting DNAse1L3PROVIDENCE HEALTH & SERVICES—OREGON·Filed 2021·Granted Jun 24, 2025·0 cites·14 claims
- 1047US2026042817A1Pet tracer for detection of transforming growth factor betaPROVIDENCE HEALTH & SERVICES OREGON·Filed 2024·Application pending·0 cites
- 1142US12560591B2Methods of treatment with CD8 T cell-mediated immune therapyPROVIDENCE HEALTH & SERVICES—OREGON·Filed 2020·Granted Feb 24, 2026·0 cites·21 claims
- 1242US2019175709A1Genetic expression of hla molecules to enhance immunotherapiesPROVIDENCE HEALTH & SERVICES OREGON·Filed 2018·Application pending·0 cites
- 1335US11464618B2Intestinal lengthening devicePROVIDENCE HEALTH & SERVICES—OREGON·Filed 2018·Granted Oct 11, 2022·0 cites·22 claims
- 1434US10925945B2Bacterial vaccines deficient in the 2-C-methyl-D-erythritol-4-phosphate pathway and methods of preparation and use thereofPROVIDENCE HEALTH & SERVICES OREGON·Filed 2015·Granted Feb 23, 2021·0 cites·24 claims
- 1533US2017239283A1Use of sting agonists to treat virally-induced and pre-malignant growthsPROVIDENCE HEALTH & SERVICES - OREGON·Filed 2017·Application pending·0 cites
- 1626US2018044428A1Compositions and methods for enhancing the efficacy of cancer therapyPROVIDENCE HEALTH & SERVICES OREGON·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PROVIDENCE HEALTH & SERVICES - OREGON files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →